Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-6876
Dr. Tang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2013 - 2017
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2013
Stanford University School of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2021 - Present
TN State Medical License 2023 - 2027
WA State Medical License 2023 - 2027
GA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
OK State Medical License 2020 - 2026
TX State Medical License 2017 - 2026
American Board of Radiology Radiation Oncology- Join now to see all
Clinical Trials
- MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial Start of enrollment: 2020 Aug 19
- Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma Start of enrollment: 2018 Jun 14
Roles: Contact, Principal Investigator
- Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer Start of enrollment: 2019 Nov 20
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Hypofractionated, Dose-Escalated Radiation Versus Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase III, Prospective, Ra...Comron Hassanzadeh, Deborah Kuban, Sarah Pasyar, Roland Bassett, Patricia Troncoso
Journal of Clinical Oncology. 2025-06-20 - Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Rando...Jarey H Wang, Alexander D Sherry, Soha Bazyar, Philip Sutera, Noura Radwan
Journal of Clinical Oncology. 2025-06-20 - Practical Considerations for the Treatment of Primary Renal Cell Carcinoma With SABR.James B Yu, David Grew, Erin Sculley, Shankar Siva, Nicholas Hardcastle
Practical Radiation Oncology. 2025-05-05
Press Mentions
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual MeetingApril 25th, 2025- Evaluating Metastasis-Directed Therapy in Oligometastatic Prostate CancerFebruary 14th, 2025
- Metastasis-Directed Therapy for Prostate Cancer a Clear Winner in Meta-AnalysisFebruary 14th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
